http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 24 Aug 2026 06:09:11 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+at+Buy/26963813.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) with a Buy rating and a price target of $8.00.</p><p>The analyst comments "Decentralized Kitted Model: IMDX is seeking to compete directly against the send-out central lab model. Instead of shipping samples for complex lab tests across the U.S., IMDX hands a local hospital lab a kit to run a similar test in-house on a Bio-Rad Droplet Digital PCR instrument. The payoff is four-fold: same-day or next-day results, the hospital retains the reimbursement economics, the test slots into the laboratory workflows that hospital labs already run, http://www.streetinsider.com/New+Coverage/Lucid+Capital+Markets+Starts+Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+at+Buy/26963813.html Mon, 24 Aug 2026 06:09:11 -0400 IMDX http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+at+Buy/26963813.html <p>Lucid Capital Markets analyst Alex Nowak initiates coverage on Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) with a Buy rating and a price target of $8.00.</p><p>The analyst comments "Decentralized Kitted Model: IMDX is seeking to compete directly against the send-out central lab model. Instead of shipping samples for complex lab tests across the U.S., IMDX hands a local hospital lab a kit to run a similar test in-house on a Bio-Rad Droplet Digital PCR instrument. The payoff is four-fold: same-day or next-day results, the hospital retains the reimbursement economics, the test slots into the laboratory workflows that hospital labs already run, http://www.streetinsider.com/Analyst+Comments/Lucid+Capital+Markets+Starts+Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+at+Buy/26963813.html Mon, 24 Aug 2026 06:09:11 -0400 IMDX http://www.streetinsider.com/Analyst+Comments/Needham%3A+%27we+think+that+the+event+was+positive+for+IMDX%27/26941195.html <p>Needham: 'we think that the event was positive for IMDX'.</p><p>The analyst comments "Yesterday, IMDX hosted a webinar with Max Jacob Liebo, MD from the Loyola University Medical Center. Dr. Liebo is a cardiologist at Loyola University Medical Center, focused on comprehensive heart and vascular care, and cares for a number of heart transplant patients. He was very positive on donor-derived cell free DNA (dd-cfDNA) testing, noting that he uses the assays in 100% of his patients and believes that over time, as clinical evidence builds, dd-cfDNA will be the primary method for both surveillance and for-cause rejection testing. He currently http://www.streetinsider.com/Analyst+Comments/Needham%3A+%27we+think+that+the+event+was+positive+for+IMDX%27/26941195.html Tue, 18 Aug 2026 08:35:44 -0400 IMDX http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Press+Releases/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html <p>NASHVILLE, Tenn., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) and Josh Riggs (iMDx CEO), to discuss the Company&apos;s GraftAssure platform, which leverages digital PCR technology to deliver reliable dd-cfDNA results for transplanted organ health monitoring. To register, <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0mF_jltKVIJPwX-9BO936zYL8nwonKyeOlkgZVpT2dWDnOO46O25EUMPHCO9MAF3VaM2KJLgsSdSz03YzebEceJf-Qn3SDueB0zJdpuQngg=" rel="nofollow" target="_blank">click here</a>.</p> <p>The event will provide an overview of GraftAssure, http://www.streetinsider.com/Globe+Newswire/Insight+Molecular+Diagnostics+to+Host+Virtual+KOL+Event+on+August+17%2C+2026%3A+Moving+Toward+In-House+Heart+Transplanted+Organ+Rejection+Testing/26905573.html Tue, 11 Aug 2026 16:05:00 -0400 A.04068911 A.06822034 A.50200942 A.50201969 IMDX O.07511324 O.20026344 O.23385737 O.29426449 O.37915788 http://www.streetinsider.com/Earnings/Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+Tops+Q2+EPS+by+1c/26898662.html <p>Insight Molecular Diagnostics Inc. (NASDAQ: IMDX) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $240 thousand versus the consensus estimate of $470.85 thousand.</p><p>For earnings history and earnings-related data on Insight Molecular Diagnostics Inc. (IMDX) <a href="http://www.streetinsider.com/ec_earnings.php?q=IMDX">click here</a>.</p> http://www.streetinsider.com/Earnings/Insight+Molecular+Diagnostics+Inc.+%28IMDX%29+Tops+Q2+EPS+by+1c/26898662.html Mon, 10 Aug 2026 16:38:17 -0400 IMDX http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Insight+Molecular+Diagno++For%3A+Jun+30/26898053.html si-local-file:///var/storage/secattach/20260810/26898053.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Insight+Molecular+Diagno++For%3A+Jun+30/26898053.html Mon, 10 Aug 2026 16:14:00 -0400 IMDX O.07511324